IBM's new anti-fraud AI chips to be made on Samsung Foundry's 5nm nodes

이재림 2024. 8. 27. 15:55
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

IBM said that its new Telum II Processor and Spyre Accelerator fraud prevention chips will be produced on Samsung's 5-nanometer nodes.
Screen capture from IBM's newsroom website [IBM]

IBM’s two new AI chips designed to prevent financial fraud will be produced on Samsung Foundry’s 5-nanometer nodes, the U.S. computing giant said on Monday.

IBM unveiled the Telum II Processor and Spyre Accelerator at Hot Chips 2024, an annual semiconductor conference held at Stanford University.

The Telum II is IBM’s second-generation AI chip that will be deployed in its next-generation IBM Z mainframe systems to prevent financial fraud. The on-chip cache capacity increased by 40 percent compared to its predecessor and includes a data processing unit.

Spyre is IBM’s first proprietary AI accelerator that complements the Telum II by providing additional computational power. It is an add-on option that enterprises can choose to include, tailored for complex AI workloads and inferences, with a maximum memory capacity of 1TB.

It is designed to consume no more than 75 watts per card.

The two chips will be manufactured by Samsung Foundry, as was the case with IBM’s preceding Telum processor.

IBM believes its two new products can mitigate risks in financial crimes such as insurance fraud and money laundering.

"The Telum II Processor and Spyre Accelerator are designed to deliver high-performance, secured and more power-efficient enterprise computing solutions,” said Tina Tarquinio, vice president of IBM’s product management for IBM Z and LinuxONE. “After years in development, these innovations will be introduced in our next generation IBM Z platform so clients can leverage LLMs and generative AI at scale."

BY LEE JAE-LIM [lee.jaelim@joongang.co.kr]

Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.

이 기사에 대해 어떻게 생각하시나요?